Projects funded by the NCN

Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

Call: PRELUDIUM 23 , Panel: ST4

Principal investigator: Monika Katarzyna Rola

Politechnika Łódzka

Anticancer drug candidates from Nostoc edaphicum CCNP1411 and Pseudanabaena galeata CCNP1313 (CYANOCRAB)

Call: OPUS 23 , Panel: NZ9

Principal investigator: prof. Hanna Jurata Mazur-Marzec

Uniwersytet Gdański, Wydział Chemii

Molecular profiling of novel antipsychotic drug candidates

Call: OPUS 20 , Panel: NZ7

Principal investigator: dr hab. Jan Manuel Rodriguez Parkitna

Instytut Farmakologii PAN

DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINO...

Call: OPUS 17 , Panel: NZ7

Principal investigator: dr hab. Oleh M. Demchuk

Katolicki Uniwersytet Lubelski Jana Pawła II, Wydział Medyczny

Modeling of quantitative structure-metabolic stability relationships as a tool to improve design of potential novel anti...

Call: OPUS 12 , Panel: NZ7

Principal investigator: prof. Tomasz Bączek

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

The determination of ADME-Tox in vitro for potential CNS-drug candidates acting as potent and selective ligands of serot...

Call: PRELUDIUM 11 , Panel: NZ7

Principal investigator: Annamaria Teresa Lubelska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Design, bio and diversity oriented synthesis of fused pyridin-4(1H)-ones, 4H-pyrane-4-ones and 4H-thiopyran-4-ones as po...

Call: POLONEZ 2 , Panel: ST5

Principal investigator: dr Satenik Mkrtchyan

Centrum Badań Molekularnych i Makromolekularnych PAN

Non-typical examples of three-component condensation of amines, phosphites and orthoformates as a source of new substanc...

Call: OPUS 1 , Panel: ST5

Principal investigator: prof. Paweł Kazimierz Kafarski

Politechnika Wrocławska, Wydział Chemiczny